Besufetamig, CAS 3037124-22-1

Product Description: Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 3037124-22-1

Molecular Weight: N/A

Research Area: Cancer; Inflammation/Immunology

Target: CD3;PD-1/PD-L1

• Artikelnummer: MEXHY-P991122-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991122-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated